Corcept Therapeutics
CORT
#2838
Rank
NZ$10.10 B
Marketcap
NZ$94.10
Share price
-2.22%
Change (1 day)
-25.41%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): NZ$9.25 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.76 Billion. In 2025 the company made an earning of NZ$0.11 Billion a decrease over its 2024 earnings that were of NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$9.25 M-91.84%
2025 NZ$0.11 B-58.84%
2024 NZ$0.27 B29.65%
2023 NZ$0.21 B7.2%
2022 NZ$0.19 B-7.05%
2021 NZ$0.21 B-5.01%
2020 NZ$0.22 B12.79%
2019 NZ$0.19 B26.61%
2018 NZ$0.15 B74.51%
2017 NZ$90.15 M548.72%
2016 NZ$13.89 M-227.03%
2015 -NZ$10.94 Million-79.58%
2014 -NZ$53.58 Million-31.79%
2013 -NZ$78.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.35 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.94 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.08 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.13 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.45 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.38 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$2.4 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-NZ$46.85 Million-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA